Results 11 to 20 of about 12,569 (203)

Carbapenem-Sparing Strategies for ESBL Producers: When and How

open access: yesAntibiotics, 2020
Extended spectrum β-lactamase (ESBL)-producing bacteria are prevalent worldwide and correlated with hospital infections, but they have been evolving as an increasing cause of community acquired infections.
Ilias Karaiskos, Helen Giamarellou
doaj   +1 more source

A Review of Extended Spectrum β-Lactamases: Definition and Types [PDF]

open access: yesKirkuk Journal of Science, 2023
Extended-spectrum β-lactamases (ESBLs) are defined as those bacterial enzymes which are capable to hydrolyze most beta-lactam antibiotics, including penicillins, cephalosporins, and the monobactam aztreonam and especially expanded spectrum cephalosporins
Mahmood Al-Hasso, Zahraa Mohialdeen
doaj   +1 more source

The Anti-Bacterial Effect of Eucalyptus and Medlar Extracts Against Klebsiella Pneumonia in Rasht Hospitals [PDF]

open access: yesJournal of Advanced Biomedical Sciences, 2020
Background & Objective: Klebsiella pneumonia is an opportunistic pathogen in nosocomial infections. Nowadays using plant-based drugs against drug resistant bacterial infections is gaining special importance.
Maryam Basboos   +2 more
doaj  

Diverse genetic characteristics of ESBL-producing Klebsiella pneumoniae isolates from obstetrics & gynaecology settings in some major hospitals, China

open access: yesClinical and Experimental Obstetrics & Gynecology, 2021
Background: We investigated the susceptibility patterns and genotype of extended-spectrum-beta-lactamase (ESBL)-producing Klebsiella pneumoniae isolates. Methods: A prospective survey of K.
Xiao-Mei Zhang   +4 more
doaj   +1 more source

Lentic and effluent water of Delhi-NCR: a reservoir of multidrug-resistant bacteria harbouring blaCTX-M, blaTEM and blaSHV type ESBL genes

open access: yesJournal of Water and Health, 2021
Antimicrobial resistance is not restricted to clinics but also spreading fast in the aquatic environment. This study focused on the prevalence and diversity of extended-spectrum β-lactamase (ESBL) genes among bacteria from lentic and effluent water in ...
Asghar Ali   +5 more
doaj   +1 more source

Extended-Spectrum Beta-Lactamases Producing Enterobacteriaceae in the USA Dairy Cattle Farms and Implications for Public Health

open access: yesAntibiotics, 2022
Antimicrobial resistance (AMR) is one of the top global health threats of the 21th century. Recent studies are increasingly reporting the rise in extended-spectrum beta-lactamases producing Enterobacteriaceae (ESBLs-Ent) in dairy cattle and humans in the
Benti Deresa Gelalcha   +1 more
doaj   +1 more source

The Impact of ESBLs-Positive Escherichia coli’s Resistance to Cefepime and Its Guidance for Clinical Treatment

open access: yesInfection and Drug Resistance, 2023
Qian Wu,1 Jing Shi,2 Juan Huang,3 Delu Gan,1 Lijun Zhang,1 Pu Li1 1Department of Laboratory Medicine, The Second Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Department of Clinical Laboratory, The First Affiliated ...
Wu Q   +5 more
doaj  

Characterization of qnrB-carrying plasmids from ESBL- and non-ESBL-producing Escherichia coli

open access: yesBMC Genomics, 2022
Abstract Background Escherichia coli carrying clinically important antimicrobial resistances [i.e., against extended-spectrum-beta-lactamases (ESBL)] are of high concern for human health and are increasingly detected worldwide.
Juraschek, Katharina   +6 more
openaire   +3 more sources

Molecular Identification of TEM and SHV Genes in Extended Spectrum Beta-lactamase Producing Escherichia coli and Klebsiellae pneumoniae Isolates in a Tertiary Care Hospital, Bangladesh

open access: yesJournal of Pure and Applied Microbiology, 2017
Extended spectrum b-lactamases (ESBLs) are enzymes encoded by mutation of a class of genes such as TEM, SHV, OXA and CTX etc. in gram negative Enterobacteriaceae.
Md. Hasanul Karim   +2 more
doaj   +1 more source

Global evaluation of the antibacterial activity of Ceftolozane/Tazobactam against ESBLs-producing and : a systematic review and meta-analysis

open access: yesTherapeutic Advances in Infectious Disease, 2023
Background: Ceftolozane/Tazobactam is a β-lactam/β-lactamase inhibitor combination with a high range of efficacy and broad-spectrum action against multidrug-resistant bacterial strains. Objectives: The present study aimed to analyze the in vitro activity
Marzieh Rahim Khorasani   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy